Join the club for FREE to access the whole archive and other member benefits.

Mimetas

Company that offers OrganoPlates and develops human tissue and disease models.

MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.

Visit website: https://mimetas.com/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

Mimetas News

Becoming Cyborg: 10 Amazing MedTech Inventions

Labiotech - 15-Dec-2015

Some of the best developments from 2015: Google contact lens with wireless chip and glucose sens...

Read more...